{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:07Z","timestamp":1786994407511,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.msard.2020.102652","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T02:23:37Z","timestamp":1606357417000},"page":"102652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study"],"prefix":"10.1016","volume":"47","author":[{"given":"Soto de Castillo","family":"Ibis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molina","family":"Omaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soto","family":"Arnoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armas","family":"Elizabeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendoza","family":"Sandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Castillo Maria","family":"Carlota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-0912","authenticated-orcid":false,"given":"Castro","family":"Elizabeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vink","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Rosalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbuena","family":"Oscar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Del Moral","family":"Luisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acosta","family":"Nahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2020.102652_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/NRL.0000000000000057","article-title":"Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features","volume":"20","author":"Altintas","year":"2015","journal-title":"Neurologist"},{"key":"10.1016\/j.msard.2020.102652_bib0002","first-page":"1","article-title":"Epidemiology of neuromyelitis optica in Latin America","author":"Alvarenga","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2020.102652_bib0003","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102652_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","article-title":"Neuromyelitis optica in Brazil: a study on clinical and prognostic factors","volume":"15","author":"Bichuetti","year":"2009","journal-title":"Mult. Scler. J.,"},{"key":"10.1016\/j.msard.2020.102652_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/741490","article-title":"Immunotherapy of Neuromyelitis optica","volume":"2013","author":"Bienia","year":"2013","journal-title":"Autoimmune Diseases"},{"key":"10.1016\/j.msard.2020.102652_bib0006","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorders and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J. Neurol"},{"issue":"8","key":"10.1016\/j.msard.2020.102652_bib0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of nmosd in australia and new zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2020.102652_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102652_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera Gomez","year":"2009","journal-title":"J Neurol,"},{"issue":"5","key":"10.1016\/j.msard.2020.102652_bib0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-020-09699-2","article-title":"Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort","volume":"267","author":"Carnero Contentti","year":"2020","journal-title":"j. Neurol"},{"key":"10.1016\/j.msard.2020.102652_bib0011","first-page":"1","article-title":"Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort","volume":"44","author":"Correa Diaz","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2020.102652_bib0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2020.102652_bib0013","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/0004-282x20160193","article-title":"Neuromyelitis optica: phenotypic characteristics in a Brazilian case series","volume":"75","author":"Del Negro","year":"2017","journal-title":"Arq. Neuropsiquiatr"},{"key":"10.1016\/j.msard.2020.102652_bib0014","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the united states commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102652_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis","author":"Etemadifar","year":"2015","journal-title":"Multiple Sclerosis International"},{"key":"10.1016\/j.msard.2020.102652_bib0016","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis optica in isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102652_bib0017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol,"},{"key":"10.1016\/j.msard.2020.102652_bib0018","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","article-title":"Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease","volume":"3","author":"Fujihara","year":"2012","journal-title":"Clinical and Exper imental Neuroimmunology"},{"key":"10.1016\/j.msard.2020.102652_bib0019","first-page":"8","article-title":"Prevalencia estimada de la neuromyelitis \u00f3ptica en Panam\u00e1","volume":"34","author":"Gracia","year":"2014","journal-title":"Rev. Med Panama,"},{"key":"10.1016\/j.msard.2020.102652_bib0020","unstructured":"Instituto Nacional de Estadistica (INE). (2015). XIV Censo Nacional de Poblacion y Vivienda. Retrieved from http\/\/www.ine.gov.ve. (accessed 6\/28\/2020)."},{"issue":"8","key":"10.1016\/j.msard.2020.102652_bib0021","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2020.102652_bib0022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clinical & Experimental Immunology,"},{"issue":"14","key":"10.1016\/j.msard.2020.102652_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102652_bib0024","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.msard.2020.102652_bib0025","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102652_bib0026","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.msard.2020.102652_bib0027","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"issue":"9451","key":"10.1016\/j.msard.2020.102652_bib0028","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A Serum Autoantibody Marker of Neuromyelitis Optica: Distinction From Multiple Sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2020.102652_bib0029","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1352458507084595","article-title":"NMO-IgG and Devic's Neuromyelitis optica: a French experience","volume":"14","author":"Marignier","year":"2008","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102652_bib0030","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of Neuromyelitis Optica in the United States","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2020.102652_bib0031","first-page":"2","article-title":"Demographic and clinical features of neuromyelitis optica: A review","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102652_bib0032","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102652_bib0033","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1352458513495580","article-title":"The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow up of the South Atlantic Project","volume":"20","author":"Papais Alvarenga,","year":"2014","journal-title":"Mult Scler J.,"},{"issue":"7","key":"10.1016\/j.msard.2020.102652_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0127757","article-title":"Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study","volume":"10","author":"Papais-Alvarenga","year":"2015","journal-title":"Plos One"},{"issue":"3","key":"10.1016\/j.msard.2020.102652_bib0037","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain Abnormalities in Neuromyelitis Optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102652_bib0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-1019131","article-title":"Neuromyelitis Optica: A New Perspective","volume":"28","author":"Pittock","year":"2008","journal-title":"Sem Neurol"},{"key":"10.1016\/j.msard.2020.102652_bib0039","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J.Neurol."},{"issue":"5","key":"10.1016\/j.msard.2020.102652_bib0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1212\/WNL.57.5.937","article-title":"Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica","volume":"57","author":"Rivera","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102652_bib0041","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1468-1331.2009.02928.x","article-title":"Relapsing Neuromyelitis Optica: Demographic and clinical features in Iranian patients","volume":"17","author":"Sahraian","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2020.102652_bib0042","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"23","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102652_bib0043","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyeitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurol"},{"key":"10.1016\/j.msard.2020.102652_bib0044","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol, 6"},{"issue":"9","key":"10.1016\/j.msard.2020.102652_bib0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/jnnp.2007.131177","article-title":"Characterization of the spectrum of demyelinating disease in Western Australia","volume":"79","author":"Wu","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:51:15Z","timestamp":1761900675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820307264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S2211034820307264"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102652","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102652"}}